Existent Coronary or Valvular Calcification, or Both and Agatston Score > 50 in at Least One Location
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification (NCT02066662) | RWTH Aachen University | 2013-07-01 |
Track Existent Coronary or Valvular Calcification, or Both and Agatston Score > 50 in at Least One Location automatically
Every clearance here is in the API, with alerts when new ones post.